Abstract
An increasing number of families, including children and the elderly, are seeking more adventurous travel in exotic parts of the world. Holiday destinations now include once-remote regions such as subSaharan Africa and New Guinea. This increase in visits to tropical and subtropical regions, combined with widespread chloroquine-resistant malaria, now places millions of Western travelers at risk of infection annually. At least 30,000 travelers from industrialized countries are reported to contract malaria each year and approximately 1 in 100 travelers who acquire Plasmodium falciparum malaria will die.
MeSH terms
-
Adult
-
Africa South of the Sahara
-
Aged
-
Antimalarials / administration & dosage
-
Antimalarials / adverse effects
-
Antimalarials / therapeutic use*
-
Atovaquone
-
Child
-
Drug Combinations
-
Drug Resistance
-
Family
-
Humans
-
Malaria / mortality
-
Malaria / prevention & control*
-
Naphthoquinones / administration & dosage
-
Naphthoquinones / adverse effects
-
Naphthoquinones / therapeutic use*
-
New Guinea
-
Proguanil / administration & dosage
-
Proguanil / adverse effects
-
Proguanil / therapeutic use*
-
Randomized Controlled Trials as Topic
-
Travel
-
United States / epidemiology
Substances
-
Antimalarials
-
Drug Combinations
-
Naphthoquinones
-
atovaquone, proguanil drug combination
-
Proguanil
-
Atovaquone